Viewing Study NCT02405858


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-02-21 @ 7:05 AM
Study NCT ID: NCT02405858
Status: COMPLETED
Last Update Posted: 2025-02-03
First Post: 2015-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy
Sponsor: Janssen Pharmaceutical K.K.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module